16.12.2012 Views

Anthem Blue Cross Blue Shield PPO Plan - Teamworks at Home ...

Anthem Blue Cross Blue Shield PPO Plan - Teamworks at Home ...

Anthem Blue Cross Blue Shield PPO Plan - Teamworks at Home ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

General exclusions<br />

In addition to any other exclusions or limit<strong>at</strong>ions<br />

specifed in this chapter, the <strong>Plan</strong> does not cover<br />

the following:<br />

• Admission for diagnostic tests th<strong>at</strong> can be performed<br />

on an outp<strong>at</strong>ient basis�<br />

• Autopsies�<br />

• Blood pressure monitoring devices�<br />

• Charges for Christian Science care in a Christian<br />

Science san<strong>at</strong>orium, unless the confnement is for a<br />

condition th<strong>at</strong> would require a person of another faith<br />

to enter a hospital�<br />

• Charges for failure to keep scheduled visits�<br />

• Charges for or associ<strong>at</strong>ed with p<strong>at</strong>ient advocacy�<br />

• Charges for furnishing medical records or reports�<br />

• Charges for giving injections th<strong>at</strong> can be<br />

self-administered�<br />

• Charges for or rel<strong>at</strong>ed to care th<strong>at</strong> is custodial or not<br />

normally provided as preventive care or tre<strong>at</strong>ment of<br />

an illness� Custodial care includes giving medicine<br />

th<strong>at</strong> can usually be taken without help, preparing<br />

special foods, and helping you to walk, get in and out<br />

of bed, dress, e<strong>at</strong>, b<strong>at</strong>he, and use the toilet�<br />

• Charges for or rel<strong>at</strong>ed to care th<strong>at</strong> is investig<strong>at</strong>ive�<br />

A drug, device, diagnostic procedure, technology,<br />

or medical tre<strong>at</strong>ment or procedure is investig<strong>at</strong>ive<br />

if reliable evidence does not permit conclusions<br />

concerning its safety, efectiveness, or efect on health<br />

outcomes as compared with the standard means<br />

of tre<strong>at</strong>ment or diagnosis� <strong>Anthem</strong> BCBS bases a<br />

decision on an examin<strong>at</strong>ion of the following reliable<br />

evidence, none of which is determin<strong>at</strong>ive in and<br />

of itself:<br />

– Any drug, biologic device, diagnostic product,<br />

equipment, procedure, tre<strong>at</strong>ment, service, or<br />

supply used in or directly rel<strong>at</strong>ed to the diagnosis,<br />

evalu<strong>at</strong>ion, or tre<strong>at</strong>ment of a disease, injury, illness,<br />

or other health condition th<strong>at</strong> the administr<strong>at</strong>or<br />

or the administr<strong>at</strong>or’s designee determines in its<br />

sole discretion to be experimental or investig<strong>at</strong>ive�<br />

The administr<strong>at</strong>or will deem any drug, biologic<br />

device, diagnostic product, equipment, procedure,<br />

tre<strong>at</strong>ment, service, or supply to be experimental or<br />

investig<strong>at</strong>ive if the administr<strong>at</strong>or determines th<strong>at</strong><br />

one or more of the following criteria apply when<br />

the service is rendered with respect to the use<br />

for which benefts are sought� The drug, biologic<br />

device, diagnostic product, equipment, procedure,<br />

tre<strong>at</strong>ment, service, or supply:<br />

38<br />

° Cannot be legally marketed in the United St<strong>at</strong>es<br />

without the fnal approval of the Food and Drug<br />

Administr<strong>at</strong>ion (FDA), or other licensing or<br />

regul<strong>at</strong>ory agency, and such fnal approval has not<br />

been granted�<br />

° Has been determined by the FDA to be<br />

contraindic<strong>at</strong>ed for the specifc use�<br />

° Is provided as part of a clinical research protocol<br />

or clinical trial or is provided in any other manner<br />

th<strong>at</strong> is intended to evalu<strong>at</strong>e the safety, toxicity, or<br />

efcacy of the drug, biologic device, diagnostic<br />

product, equipment, procedure, tre<strong>at</strong>ment, service,<br />

or supply�<br />

° Is subject to review and approval of an<br />

Institutional Review Board (IRB) or other body<br />

serving a similar function�<br />

° Is provided pursuant to informed consent<br />

documents th<strong>at</strong> describe the drug, biologic<br />

device, diagnostic product, equipment, procedure,<br />

tre<strong>at</strong>ment, service, or supply as experimental<br />

or investig<strong>at</strong>ive, or otherwise indic<strong>at</strong>e th<strong>at</strong> the<br />

safety, toxicity, or efcacy of the drug, biologic<br />

device, diagnostic product, equipment, procedure,<br />

tre<strong>at</strong>ment, service, or supply is under evalu<strong>at</strong>ion�<br />

– Any service not deemed experimental or<br />

investig<strong>at</strong>ive based on the criteria above may still<br />

be deemed experimental or investig<strong>at</strong>ive by the<br />

administr<strong>at</strong>or� In determining whether a service<br />

is experimental or investig<strong>at</strong>ive, the administr<strong>at</strong>or<br />

will consider the inform<strong>at</strong>ion described below and<br />

assess whether:<br />

° The scientifc evidence is conclusory concerning<br />

the efect of the service on health outcomes�<br />

° The evidence demonstr<strong>at</strong>es th<strong>at</strong> the service<br />

improves net health outcomes of the total<br />

popul<strong>at</strong>ion for whom the service might be<br />

proposed by producing benefcial efects th<strong>at</strong><br />

outweigh any harmful efects�<br />

° The evidence demonstr<strong>at</strong>es th<strong>at</strong> the service<br />

has been shown to be benefcial for the total<br />

popul<strong>at</strong>ion for whom the service might be<br />

proposed as any established altern<strong>at</strong>ives and<br />

the evidence demonstr<strong>at</strong>es the service has been<br />

shown to improve the net health outcomes of the<br />

total popul<strong>at</strong>ion for whom the service might be<br />

proposed under the usual conditions of medical<br />

practice outside clinical investig<strong>at</strong>ory settings�<br />

– The inform<strong>at</strong>ion considered or evalu<strong>at</strong>ed by the<br />

administr<strong>at</strong>or to determine whether a drug, biologic<br />

device, diagnostic product, equipment, procedure,<br />

tre<strong>at</strong>ment, service, or supply is experimental or<br />

<strong>Anthem</strong> <strong>Blue</strong> <strong>Cross</strong> <strong>Blue</strong> <strong>Shield</strong> <strong>PPO</strong> <strong>Plan</strong>

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!